Elite Pharmaceuticals to release Q1 FY2027 results Aug 13; earnings call Aug 14

ELITE PHARMACEUTICALS INC /NV/

Q1 FY2027 (ended June 30, 2026) financial results to be released Thursday, August 13, 2026.
Conference call Friday, August 14, 2026, 11:30 AM EDT; dial-in 1-800-346-7359 (domestic) or 1-973-528-0008 (international).
Conference number 98840; general questions due Aug 12, financial questions due Aug 13 via dianne@elitepharma.com.
Call to cover financial/operating results and provide a general business update; audio replay available at elite.irpass.com.
Company develops and distributes niche generic oral controlled-release products from Northvale, NJ facility.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.